Trials that use: Risk difference
New to this method? Read the tutorial →
4,772 results
- Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): Complete Statistical AnalysisIndependent statistical analysis of Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976741).
- Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): primary endpoint results, effect…
- Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose Optimization Trial of CD19 Redirected Autologous T Cells: Complete Statistical AnalysisIndependent statistical analysis of Dose Optimization Trial of CD19 Redirected Autologous T Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747486).
- Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): primary endpoint results,…
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: primary endpoint results, effect estimate with…
- Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: Complete Statistical AnalysisIndependent statistical analysis of Dose the Saline Reduce the Mucus Production When Water Exchange Colonoscopy is Used?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence…
- Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DoseFlexIndependent statistical analysis of Dosing Flexibility Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580840).
- Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Double-J PLUS Postmarket Registry Study: Complete Statistical AnalysisIndependent statistical analysis of Double-J PLUS Postmarket Registry Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04197583).
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DOXY-PEPIndependent statistical analysis of Doxy-Post-exposure Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05853120).
- Doxycycline, Temozolomide and Ipilimumab in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Doxycycline, Temozolomide and Ipilimumab in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590082).
- DPARTIndependent statistical analysis of Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04487145).
- DREAMM 5Independent statistical analysis of Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM): primary endpoint results, effect estimate with confidence interval,…
- DRIPSIndependent statistical analysis of Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919436).
- Drug Interaction Study of Digoxin and BI 10773: Complete Statistical AnalysisIndependent statistical analysis of Drug Interaction Study of Digoxin and BI 10773: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01306175).
- Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate: Complete Statistical AnalysisIndependent statistical analysis of Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE): Complete Statistical AnalysisIndependent statistical analysis of Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients: Complete Statistical AnalysisIndependent statistical analysis of Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227395).
- Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01303445).
- Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05064488).
- Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DSAEKIndependent statistical analysis of Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744796).
- DSC2UIndependent statistical analysis of An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DSTIndependent statistical analysis of CoolSculpting of the Distal Thigh Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335749).
- DUAOIndependent statistical analysis of Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00496080).
- DUARTIndependent statistical analysis of Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: primary endpoint results, effect estimate with confidence interval, sample-size…
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): Complete Statistical AnalysisIndependent statistical analysis of Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: Complete Statistical AnalysisIndependent statistical analysis of Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…